Take Your Trading To The Next Level. Get Started Here!

Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly

September 28, 2022 Comments Off

We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly.